JP2003513935A5 - - Google Patents

Download PDF

Info

Publication number
JP2003513935A5
JP2003513935A5 JP2001536186A JP2001536186A JP2003513935A5 JP 2003513935 A5 JP2003513935 A5 JP 2003513935A5 JP 2001536186 A JP2001536186 A JP 2001536186A JP 2001536186 A JP2001536186 A JP 2001536186A JP 2003513935 A5 JP2003513935 A5 JP 2003513935A5
Authority
JP
Japan
Prior art keywords
biotype
mycoplasma bovis
inactivated
vaccine
attenuated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001536186A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003513935A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2000/042000 external-priority patent/WO2001034189A2/en
Publication of JP2003513935A publication Critical patent/JP2003513935A/ja
Publication of JP2003513935A5 publication Critical patent/JP2003513935A5/ja
Pending legal-status Critical Current

Links

JP2001536186A 1999-11-08 2000-11-08 マイコプラズマ・ボビスに対するワクチンおよび使用方法 Pending JP2003513935A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16428699P 1999-11-08 1999-11-08
US60/164,286 1999-11-08
PCT/US2000/042000 WO2001034189A2 (en) 1999-11-08 2000-11-08 Vaccines for mycoplasma bovis and methods of use

Publications (2)

Publication Number Publication Date
JP2003513935A JP2003513935A (ja) 2003-04-15
JP2003513935A5 true JP2003513935A5 (enExample) 2007-12-27

Family

ID=22593810

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001536186A Pending JP2003513935A (ja) 1999-11-08 2000-11-08 マイコプラズマ・ボビスに対するワクチンおよび使用方法

Country Status (10)

Country Link
US (7) US7943153B1 (enExample)
EP (1) EP1229929A2 (enExample)
JP (1) JP2003513935A (enExample)
AU (1) AU782508B2 (enExample)
BR (1) BR0015398A (enExample)
CA (1) CA2390613A1 (enExample)
IL (1) IL149471A0 (enExample)
MX (1) MXPA02004627A (enExample)
WO (1) WO2001034189A2 (enExample)
ZA (1) ZA200203622B (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2390613A1 (en) * 1999-11-08 2001-05-17 Biomune Vaccines for mycoplasma bovis and methods of use
GB0110851D0 (en) * 2001-05-03 2001-06-27 Mini Agriculture & Fisheries Vaccine
US20030147914A1 (en) * 2001-07-02 2003-08-07 Pfizer Inc. Mycoplasma bovis vaccine and methods of reducing pneumonia in animals
BR0211563A (pt) * 2001-08-28 2004-07-13 Pfizer Prod Inc Modelo de infecção por mycoplasma bovis e métodos para administração de m. bovis e para indução de lesões pneumÈnicas do pulmão
US20110059437A1 (en) * 2006-09-07 2011-03-10 Boehringer Ingelheim Vetmedica, Inc. Pcr-based genotyping
CL2008003202A1 (es) 2007-10-29 2009-11-27 Boehringer Ingelheim Vetmedica Inc Composicion inmunogenica que comprende bacterias vivas de mycoplasma bovis atenuada avirulenta.
US9056909B2 (en) * 2007-11-06 2015-06-16 Zoetis Services Llc Mycoplasma hyopneumoniae avirulent adjuvanted live vaccine
EP2163239A1 (de) * 2008-05-27 2010-03-17 Qiagen GmbH Produkte, die Biopartikel enthalten, Verfahren zu ihrer Herstellung
EP2320943B1 (en) * 2008-07-03 2016-02-17 Iowa State University Research Foundation, Inc. Cattle vaccines
SG10201506597RA (en) 2008-10-31 2015-10-29 Boehringer Ingelheim Vetmed Use Of Various Antigens Including Antigens From Mycoplasma Bovis In Multivalent Vaccine Composition
UY32570A (es) * 2009-04-24 2010-11-30 Boehringer Ingelheim Vetmed Vacuna viva modificada de mycoplasma bovis mejorada
WO2010140377A1 (ja) 2009-06-04 2010-12-09 独立行政法人産業技術総合研究所 マイコプラズマ感染症用ワクチン
WO2011044576A2 (en) 2009-10-09 2011-04-14 Children's Medical Center Corporation Selectively disrupted whole-cell vaccine
EP2621951A1 (en) * 2010-09-29 2013-08-07 Université de Liège Combination of an agonistic anti-cd40 monoclonal antibody or a cd40 ligand and inactivated or attenuated bacteria for use in the treatment and/or prevention of mastitis
US9052315B2 (en) 2012-05-09 2015-06-09 Advanced Animal Diagnostics, Inc. Rapid detection of analytes in liquid samples
US10359614B2 (en) 2012-07-03 2019-07-23 Advanced Animal Diagnostics, Inc. Diagnostic apparatus
HUE059179T2 (hu) 2012-09-10 2022-10-28 Galenbio Inc Vízimadárban Mycoplasma-fertõzés megelõzésére szolgáló oltóanyag
US9797893B2 (en) 2013-05-09 2017-10-24 Advanced Animal Diagnostics, Inc. Rapid detection of analytes in liquid samples
DK3334454T3 (da) 2015-08-14 2022-11-14 Zoetis Services Llc Mycoplasma-Bovis-sammensætninger
CN110338138B (zh) * 2019-06-19 2021-04-06 山东省农业科学院奶牛研究中心 一种牛支原体感染豚鼠的动物模型构建方法及其应用
CN113040094B (zh) * 2021-03-18 2022-06-21 中国农业大学 一种牛支原体性小鼠乳腺炎模型的构建方法及其应用
CN116751723A (zh) * 2023-07-24 2023-09-15 吉林农业大学 一种牛支原体菌株及其灭活疫苗和应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0043272B1 (en) 1980-07-01 1984-06-13 National Research Development Corporation Production of viral antigens
US4425330A (en) * 1981-05-20 1984-01-10 Cornell Research Foundation, Inc. Bovine mastitis vaccine and method for detecting efficacy thereof
US4517394A (en) * 1983-07-05 1985-05-14 W. R. Grace & Co. Preparation of nitro compounds by vapor phase nitration of carboxylic acids
US5178860A (en) 1989-09-01 1993-01-12 Coopers Animal Health Limited Adjuvant complexes and vaccine made therefrom
US4981684A (en) 1989-10-24 1991-01-01 Coopers Animal Health Limited Formation of adjuvant complexes
US5565205A (en) 1990-08-16 1996-10-15 Solvay Animal Health, Inc. Inactivated Mycoplasma hypopneumoniae bacterin and method of use thereof
CA2057946A1 (en) * 1990-12-20 1992-06-21 Michael M. Thackeray Electrochemical cell
US5316875A (en) * 1991-07-19 1994-05-31 Matsushita Electric Industrial Co., Ltd. Secondary battery with nonaqueous electrolyte and method of manufacturing same
US5338543A (en) 1992-02-27 1994-08-16 Ambico, Inc. Thimerosal inactivated mycoplasma hyopneumoniae vaccine
US5585098A (en) 1993-11-23 1996-12-17 Ovimmune, Inc. Oral administration of chicken yolk immunoglobulins to lower somatic cell count in the milk of lactating ruminants
DK0744937T3 (da) * 1994-02-18 2002-10-28 Solidose L L C Vaccination af dyr med tørrede, pelleterede biologiske materialer
JP3702353B2 (ja) * 1996-05-24 2005-10-05 日本電池株式会社 リチウム電池用正極活物質の製造方法およびリチウム電池
CA2390613A1 (en) * 1999-11-08 2001-05-17 Biomune Vaccines for mycoplasma bovis and methods of use
DE29921392U1 (de) 1999-12-06 2000-03-16 Dr. Felgenträger & Co. Öko-Chem. und Pharma GmbH, 06862 Rodleben Mykoplasma-bovis-Kombinations-Vakzine für Rinder
US6677082B2 (en) * 2000-06-22 2004-01-13 The University Of Chicago Lithium metal oxide electrodes for lithium cells and batteries
US6680143B2 (en) * 2000-06-22 2004-01-20 The University Of Chicago Lithium metal oxide electrodes for lithium cells and batteries
JP3500424B2 (ja) * 2000-08-31 2004-02-23 独立行政法人産業技術総合研究所 単相リチウムフェライト系複合酸化物
US6548069B2 (en) 2001-02-03 2003-04-15 Hmv Associates, Inc. Multivalent Mycoplasma bacterin

Similar Documents

Publication Publication Date Title
RU2349342C2 (ru) Менингококковые вакцины для введения через слизистую оболочку
RU2004136295A (ru) Комбинированные вакцины против бактериального менингита для введения через слизистую оболочку
WO2003003941A3 (en) One dose vaccination with mycoplasma hyopneumoniae
NO20015073D0 (no) Vaksiner
ES2257769T3 (es) Metodo para la preparacion de vacunas multivalentes.
JP5713672B2 (ja) 結核のワクチンおよびその使用方法
JP2004536106A5 (enExample)
ITMI20111182A1 (it) Vaccino per coronavirus canino
JP2002512026A5 (enExample)
JP2002531521A5 (enExample)
EP3549600B1 (en) A vaccine for protection against streptococcus suis
WO2001034189A3 (en) Vaccines for mycoplasma bovis and methods of use
US11167021B2 (en) Vaccine for protection against Streptococcus suis
KR20030015288A (ko) 보조제 배합물로서의 큐에스-21 및 아이엘-12
Stephen et al. Swine influenza virus vaccine: potentiation of antibody responses in rhesus monkeys
CA2931139C (en) Swine vaccine against prrs and lawsonia intracellularis
US5928649A (en) Method of reversing immunosuppression in vaccines
JP2009514840A5 (enExample)
WO1999053950A3 (en) Live vaccines and methods of treatment therewith
JP2003519089A (ja) 肺炎球菌表面型蛋白質配合ワクチン
EP1237573B1 (fr) Utilisation de proteines immunogenes immunosuppressives ou angiogeniques rendues inactives pour la production d'lga secretoires
Cohen et al. Two injections of diphtheria-tetanus-pertussis-polio vaccine as the backbone of a simplified immunization schedule in developing countries
RU2227160C1 (ru) Штамм бактерий leptospira interrogans "митронов" серогруппы canicola для приготовления вакцины
RU2291709C1 (ru) Способ иммунопрофилактики вирусных респираторных болезней телят
Salmon Humoral lactogenic immunity in the sow: basis and practice.